Sunshine Biopharma (SBFM) Insider Trading & Ownership $2.91 +0.01 (+0.34%) Closing price 04:00 PM EasternExtended Trading$2.91 0.00 (0.00%) As of 04:51 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Sunshine Biopharma (NASDAQ:SBFM) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage0.10%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$10,000.00Number OfInsiders Selling(Last 12 Months)0 Get SBFM Insider Trade Alerts Want to know when executives and insiders are buying or selling Sunshine Biopharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address SBFM Insider Buying and Selling by Quarter Sunshine Biopharma Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails3/4/2024Steve N SlilatyCEOBuy1,000$10.00$10,000.00 (Data available from 1/1/2013 forward) SBFM Insider Trading Activity - Frequently Asked Questions Who is on Sunshine Biopharma's Insider Roster? The list of insiders at Sunshine Biopharma includes Camille Sebaaly, and Steve N Slilaty. Learn more on insiders at SBFM. What percentage of Sunshine Biopharma stock is owned by insiders? 0.10% of Sunshine Biopharma stock is owned by insiders. Learn more on SBFM's insider holdings. Which Sunshine Biopharma insiders have been buying company stock? The following insider purchased SBFM shares in the last 24 months: Steve N Slilaty ($10,000.00). How much insider buying is happening at Sunshine Biopharma? Insiders have purchased a total of 1,000 SBFM shares in the last 24 months for a total of $10,000.00 bought. Sunshine Biopharma Key ExecutivesDr. Steve N. Slilaty Ph.D. (Age 72)CEO, President & Chairman Compensation: $640kMr. Camille Sebaaly (Age 65)CFO & Secretary Compensation: $695kDr. Abderrazzak Merzouki (Age 60)Chief Science Officer & Director Compensation: $340kMr. Marc Beaudoin (Age 57)Chief Operating Officer Mr. Malek Chamoun (Age 39)Chief Development Officer Mr. Robert G. Ferreira (Age 62)President of Sunshine Bio Investments Inc More Insider Trading Tools from MarketBeat Related Companies HCWB Insider Trading FLGC Insider Trading SNSE Insider Trading IMNN Insider Trading BGXX Insider Trading AIM Insider Trading HOTH Insider Trading RLMD Insider Trading CLDI Insider Trading TXMD Insider Trading Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles 3 Stocks With Strong Capital Returns and Insider Buying SignalsZymeworks in Focus for Insider Activity: Catalysts AheadInsiders Are Loading Up: 3 Key Stock Picks for InvestorsInsiders Are Selling, But These 3 Stocks Are Must-Buys3 Stocks That Wall Street Insiders Can’t Stop Buying This page (NASDAQ:SBFM) was last updated on 1/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe crypto bull market is here, and the stakes couldn’t be higher. The next 3-6 months? They’re the most ex...Crypto Swap Profits | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sunshine Biopharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sunshine Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
